Cancer vaccine (Therapeutic Solutions)

N/A

Report date: 2022/11/27 13:48:52

Base Information

Drug NameCancer vaccine (Therapeutic Solutions)
Drug Alias NameBRS-001
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine +[4] 
Mechanisms of ActionT lymphocytes stimulantsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPan American Cancer Treatment CenterEmvolio
China Registration ClassN/A

Develop Information

Active CompaniesEmvolioPan American Cancer Treatment Center
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A